To study KCNMA1 function required for human glioma progression, the glioblastoma cell line DBTRG-05MG, a heterozygous mutant carrying BRAFV600E, was employed in our study together with other two glioblastoma cell lines (U87-MG and T98G) with wt BRAF as controls. Here, BRAF is linked to central nervous system cancer.